Perella Weinberg Partners Capital Management LP Gilead Sciences, Inc. Transaction History

Perella Weinberg Partners Capital Management LP

$935 Million
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $3.16 Million - $3.48 Million	50,500 New	50,500 $3.2 Million
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $792,505 - $887,813	-12,674 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $767,283 - $1 Million	12,674 New	12,674 $793,000
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $2.32 Million - $2.71 Million	-35,790 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $2.61 Million - $3.18 Million	35,790 New	35,790 $2.7 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $492,927 - $578,626	-6,928 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $434,679 - $515,213	-6,028 Reduced 46.53%	6,928 $561,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,956	12,956 $917,000

Others Institutions Holding GILD

# of Institutions

1,963

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.86M

Black Rock Inc. New York, NY

121M
Shares

$11.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$11.2 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.44 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$6.01 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.85 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perella Weinberg Partners Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Perella Weinberg Partners Capital Management LP with notifications on news.

Account